CTRI/2013/04/003582已完成未知
Efficacy of add on therapy of Vildagliptin versus Pioglitazone in inadequately controlled Type 2 Diabetes Mellitus patients on dual therapy of Metformin plus Sulfonylurea
investigator initiated trial0 个研究点目标入组 50 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Type 2 DM, taking a combination of metformin + sulfonylurea (glibenclamide or glipizide or gliclazide or glimepride) for at least last 3 months with HbA1c >7% <=11%, BMI >25 kg/m2, FBS >126 mg/dl
排除标准
- •Pregnant and lactating females, patients on insulin therapy, history of type 1 DM, evidence of diabetic complications (nephropathy, neuropathy and retinopathy), patients with clinical signs and symptoms of acute myocardial infarction, liver failure, chronic heart failure and renal failure
研究者
相似试验
尚未招募
4 期
A comparatative trial of two gliptins - linagliptin and vildagliptin - in diabetic patientsCTRI/2024/06/068837Dr. Harshad Venugopal Ramineni
未知
3 期
Efficacy and safety of vildagliptin as add-on therapy to metformin in patients with type 2 diabetesType 2 diabetes mellitusJPRN-jRCT2080221679ovartis Pharma K.K.136
已完成
4 期
Comparison of utility of Viladagliptin 50 mg tablet twice daily and metformin combination therapy with Vildagliptin 100 mg sustained release tablet once daily and metformin combination therapy in Indian patients with type 2 diabetes mellitus: A randomized open label phase IV clinical trialCTRI/2021/10/037574Dr Rudra Paul
招募中
不适用
Comparison of efficacy and safety of Vildagliptin and Teneligliptin in patients with Type 2 Diabetes MellitusCTRI/2017/02/007766jawaharlal nehru medical college and hospital160
未知
3 期
To Compare the Efficacy and Safey of Vildagliptin Compared to Voglibose in Patients With Type 2 DiabetesType 2 DiabetesJPRN-jRCT2080220294ovartis Pharma K.K.370